Skip to main content

Table 1 Clinical and Demographic Description of PD patients

From: Cognitive characteristics in Chinese non-demented PD patients based on gender difference

  PD (n = 60) Male PD (n = 30) Female PD (n = 30)
Age(yr) 59.05 ± 9.55 58.67 ± 10.23 59.43 ± 8.98
Age of onset(yr) 54.97 ± 10.42 54.4 ± 11.38 55.53 ± 9.53
Handedness(L/R)(n) 0/60 0/30 0/30
Educational level(yr) 12.86 ± 2.97 13.1 ± 2.94 12.61 ± 3.03
Duration of illness(yr) 4.22 ± 5.33 4.37 ± 4.85 4.07 ± 5.85
Hoehn and Yahr stage 1.73 ± 0.8 1.92 ± 0.81 1.54 ± 0.76
UPDRS—Part III (“off” medication) 24.81 ± 12.04 24.42 ± 13.32 25.19 ± 10.92
Medication(n) 31/60 15/30 16/30
 MAOI-B 4 1 3
 Dopamine agonist 7 2 5
 Levodopa 9 5 4
 Levodopa and dopamine agonist 12 7 5
 Levodopa and MAOI-B 2 1 1
 Dopamine agonist and MAOI-B 1 1 0
Medication(equivalent) 472.74 ± 293.16 483.73 ± 293.69 460.28 ± 302.34
BDI 12.44 ± 9.06 12.48 ± 10.88 12.39 ± 7.08
MMSE 28.98 ± 1.07 28.97 ± 0.81 29 ± 1.29
  1. Note. UPDRS Unified parkinson’s disease rating scale, MAOI-B Monoamine oxidase inhibitor type B, BDI Beck depression inventory, MMSE Mini-mental state examination